| Diagnostic point-of-care tests in resource-limited settings PK Drain, EP Hyle, F Noubary, KA Freedberg, D Wilson, WR Bishai, ... The Lancet infectious diseases 14 (3), 239-249, 2014 | 762 | 2014 |
| The survival benefits of AIDS treatment in the United States RP Walensky, AD Paltiel, E Losina, LM Mercincavage, BR Schackman, ... The Journal of infectious diseases 194 (1), 11-19, 2006 | 752 | 2006 |
| Expanded screening for HIV in the United States—an analysis of cost-effectiveness AD Paltiel, MC Weinstein, AD Kimmel, GR Seage III, E Losina, H Zhang, ... New England Journal of Medicine 352 (6), 586-595, 2005 | 702 | 2005 |
| The cost effectiveness of combination antiretroviral therapy for HIV disease KA Freedberg, E Losina, MC Weinstein, AD Paltiel, CJ Cohen, GR Seage, ... New England Journal of Medicine 344 (11), 824-831, 2001 | 641 | 2001 |
| The lifetime cost of current human immunodeficiency virus care in the United States BR Schackman, KA Gebo, RP Walensky, E Losina, T Muccio, PE Sax, ... Medical care 44 (11), 990-997, 2006 | 595 | 2006 |
| The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men SJ Goldie, KM Kuntz, MC Weinstein, KA Freedberg, ML Welton, ... Jama 281 (19), 1822-1829, 1999 | 531 | 1999 |
| Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa CB Holmes, E Losina, RP Walensky, Y Yazdanpanah, KA Freedberg Clinical infectious diseases 36 (5), 652-662, 2003 | 421 | 2003 |
| HIV/AIDS, undernutrition, and food insecurity LC Ivers, KA Cullen, KA Freedberg, S Block, J Coates, P Webb, KH Mayer Clinical Infectious Diseases 49 (7), 1096-1102, 2009 | 360 | 2009 |
| Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire SJ Goldie, Y Yazdanpanah, E Losina, MC Weinstein, X Anglaret, ... New England Journal of Medicine 355 (11), 1141-1153, 2006 | 331 | 2006 |
| 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus 1997 USPHS/IDSA Prevention of Opportunistic Infections Working Group Clinical Infectious Diseases 30 (Supplement_1), S29-S65, 2000 | 331* | 2000 |
| Prevention of prescription opioid misuse and projected overdose deaths in the United States Q Chen, MR Larochelle, DT Weaver, AP Lietz, PP Mueller, S Mercaldo, ... JAMA network open 2 (2), e187621-e187621, 2019 | 322 | 2019 |
| Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection TM Allen, M Altfeld, XG Yu, KM O'Sullivan, M Lichterfeld, S Le Gall, ... Journal of virology 78 (13), 7069-7078, 2004 | 322 | 2004 |
| HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness AD Paltiel, KA Freedberg, CA Scott, BR Schackman, E Losina, B Wang, ... Clinical Infectious Diseases 48 (6), 806-815, 2009 | 312 | 2009 |
| Alcohol consumption and antiretroviral adherence among HIV‐infected persons with alcohol problems JH Samet, NJ Horton, S Meli, KA Freedberg, A Palepu Alcoholism: Clinical and Experimental Research 28 (4), 572-577, 2004 | 310 | 2004 |
| Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness MC Weinstein, SJ Goldie, E Losina, CJ Cohen, JD Baxter, H Zhang, ... Annals of internal medicine 134 (6), 440-450, 2001 | 308 | 2001 |
| Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs AD Paltiel, RP Walensky, BR Schackman, GR Seage III, ... Annals of internal medicine 145 (11), 797-806, 2006 | 271 | 2006 |
| The cost-effectiveness of preventing AIDS-related opportunistic infections KA Freedberg, JA Scharfstein, GR Seage III, E Losina, MC Weinstein, ... Jama 279 (2), 130-136, 1998 | 267 | 1998 |
| Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus–negative homosexual and bisexual men SJ Goldie, KM Kuntz, MC Weinstein, KA Freedberg, JM Palefsky The American journal of medicine 108 (8), 634-641, 2000 | 265 | 2000 |
| CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment CB Holmes, R Wood, M Badri, S Zilber, B Wang, G Maartens, H Zheng, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (4), 464-469, 2006 | 263 | 2006 |
| Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis PE Sax, R Islam, RP Walensky, E Losina, MC Weinstein, SJ Goldie, ... Clinical infectious diseases 41 (9), 1316-1323, 2005 | 262 | 2005 |
